COVID-19: investing in country capacity to bridge science, policy and action
Open Access
- 17 February 2021
- journal article
- editorial
- Published by BMJ in BMJ Global Health
- Vol. 6 (2), e005012
- https://doi.org/10.1136/bmjgh-2021-005012
Abstract
No abstract availableFunding Information
- World Health Organization
This publication has 7 references indexed in Scilit:
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsThe New England Journal of Medicine, 2021
- Covid-19: Order to reschedule and delay second vaccine dose is “totally unfair,” says BMAPublished by BMJ ,2020
- What Can COVID-19 Tell Us About Evidence-Based Management?The American Review of Public Administration, 2020
- Are Populist Leaders Creating the Conditions for the Spread of COVID-19? Comment on "A Scoping Review of Populist Radical Right Parties’ Influence on Welfare Policy and its Implications for Population Health in Europe"International Journal of Health Policy and Management, 2020
- Amplifying the role of knowledge translation platforms in the COVID-19 pandemic responseHealth Research Policy and Systems, 2020
- The evidence ecosystem in South Africa: growing resilience and institutionalisation of evidence usePalgrave Communications, 2019
- Business not as usual: how multisectoral collaboration can promote transformative change for health and sustainable developmentBMJ, 2018